Why does skin cancer medicine belong in primary care — and why does it matter?
As Dr Robert West explains, skin cancer is one of the most common cancers in North America, and primary care clinicians are at the front line of early detection, even in areas with dermatology services. He sees a growing gap between demand for screening and the number of specialists available.
In the below interview with Dr John Howard, he discusses why developing confidence in skin cancer diagnosis can make a meaningful difference for patients and have such a significant impact on melanoma outcomes.
The MoleScan Skin Cancer Medicine Accelerator Program is a guided pathway built specifically for North American primary care clinicians. The program includes:
Certificate-level training in dermoscopy, biopsy, and excision
Practice Implementation Toolkit for billing, workflow, and patient education
Peer mentoring and case discussions
One-time program fee of $899 (USD) – time-limited 4-course offer